Sign in
CompletedNo phase

Longitudinal Monitoring of Inflammation in Cirrhosis

Key facts

Who runs it
Hunter Holmes Mcguire Veteran Affairs Medical Center
Where
Richmond, United StatesSee the site
Trial code
Status
Completed
People taking part
85 people enrolled
Started
1 Sept 2022
Ended
31 Jul 2024
Type of study
Interventional, 3 groups
Treatments tested
  • Sensor skin
Record updated
2 August 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (20)Hide the full registry criteria

Who can take part

  • Age >18 years
  • Able to give consent
  • Age >18 years
  • Able to give consent
  • Cirrhosis defined by any one of the following; Cirrhosis on liver biopsy or transient wave elastography; Nodular liver on imaging; Endoscopic or radiological evidence of varices in a patient with chronic liver disease; Platelet count <150,000/mm3 and AST/ALT ratio >1 in a patient with chronic liver disease; Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)
  • Age >18 years
  • Able to give consent
  • Cirrhosis defined by any one of the following; Cirrhosis on liver biopsy or transient wave elastography; Nodular liver on imaging; Endoscopic or radiological evidence of varices in a patient with chronic liver disease; Platelet count <150,000/mm3 and AST/ALT ratio >1 in a patient with chronic liver disease; Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)

Who cannot take part

  • Chronic diseases
  • Inflammatory bowel disease or other diseases that require immunosuppressive therapy use; Inpatients with Cirrhosis:
  • Inflammatory bowel disease or other diseases that require immunosuppressive therapy use
  • Unable/unwilling to consent
  • Unable to come in daily or be available daily for 3 days; Outpatients with Cirrhosis:
  • Unable/unwilling to consent
  • Unclear diagnosis of cirrhosis
  • Unable to come in daily or be available daily for 3 days
  • Unable/unwilling to consent
  • Unclear diagnosis of cirrhosis
  • Unable to be seen daily or able to come in daily for 3 days (if discharged in between)

Other criteria

  • Healthy Volunteers

Where in United States

  • Hunter Holmes McGuire VA Medical CenterRichmond, United States

About the trial

What the trial wants to find out

Longitudinal monitoring of inflammation using skin devices may help predict outcomes compared to traditional blood draws

The 3 groups in the trial

  • Healthy controlsTreatment being tested

    Healthy controls will receive the sensors

    Treatment: Sensor skin

  • Outpatients with cirrhosisTreatment being tested

    Outpatients with cirrhosis will receive the sensors

    Treatment: Sensor skin

  • Inpatients with cirrhosisTreatment being tested

    Inpatients with cirrhosis will receive the sensors

    Treatment: Sensor skin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 August 2024